Proton Therapy Websites: Information Anarchy Creates Confusion

  title={Proton Therapy Websites: Information Anarchy Creates Confusion},
  author={Marnique Basto and Matthew R. Cooperberg and Declan G. Murphy},
  journal={BJU International},
Comments Correspondence: John Withington, Department of Urology, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK. e-mail: Abbreviations: HES, Hospital Episode Statistics; PCNL, percutaneous nephrolithotomy; SCTS, Society of Cardiothoracic Surgeons. Proton Therapy Websites: Information Anarchy Creates Confusion Marnique Basto, Matthew R. Cooperberg* and Declan G. Murphy Division of Cancer Surgery, University of Melbourne, Peter MacCallum Cancer Centre, Melbourne… 
Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based?
Information from PTC websites often differs from recommendations found in international consensus guidelines, and alignment of such information with accepted guidelines and consensus opinion should be adopted by PTC providers.
Hospital Choice in Cancer Care: A Qualitative Study.
Trends, Quality, and Readability of Online Health Resources on Proton Radiotherapy.
  • S. Sha, S. Perni, E. Dee
  • Medicine
    International journal of radiation oncology, biology, physics
  • 2020
Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study
Evidence and impact of NHS choice and competition policies on the delivery of prostate cancer services : a national population based evaluation
Investigation of the role of choice and competition policies on the delivery of specialist cancer services in the NHS demonstrates unequivocally that patient mobility and hospital competition is occurring within the NHS.


Proton-Beam Therapy for Prostate Cancer
  • A. Kagan, R. Schulz
  • Medicine
    Technology Evaluation Center Assessment Program. Executive summary
  • 2011
It is reasonable to assess the viability of this in-vogue but not-so-new technology, whose dose distributions make it possible to deliver higher tumor doses and smaller doses to surrounding normal tissues than from x-ray systems.
Re: Proton vs intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
A national sample of Medicare beneficiaries with prostate cancer was used to investigate the patterns and cost of PRT delivery, as well as the early treatment-related toxicity associated with PRT compared with IMRT.
Proton beam radiotherapy in the U.S. Medicare population: growth in use between 2006 and 2009
Proton beam radiotherapy is preferred for solid tumors in children because it minimizes detrimental effects of radiation on developing structures surrounding the tumor and reduces the risk of long-term side effects and the number of Medicare beneficiaries receiving proton beam therapy nearly doubled.
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
Although PRT is substantially more costly than IMRT, there was no difference in toxicity in a comprehensive cohort of Medicare beneficiaries with prostate cancer at 12 months post-treatment.
Proton beam therapy and localised prostate cancer: current status and controversies
New technical advances in proton beam delivery coupled with shortened overall treatment times and declining device costs have the potential to make this a more cost-effective therapy in the years ahead.
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis
The present study is the most comprehensive cost‐effectiveness analysis to date for localised prostate cancer, conducted with a lifetime horizon and accounting for survival, health‐related quality‐of‐life, and cost impact of secondary treatments and other downstream events, as well as primary treatment choices.
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.
Among patients with nonmetastatic prostate cancer, the use of IM RT compared with conformal radiation therapy was associated with less gastrointestinal morbidity and fewer hip fractures but more erectile dysfunction; IMRT compared with proton therapy wasassociated with lessintestinal morbidity.
Robotic Surgery Claims on United States Hospital Websites
Material provided by hospitals regarding the surgical robot overestimate benefits, largely ignore risks and are strongly influenced by the manufacturer.
Dosimetry Aspects of Proton Therapy
  • B. Patyal
  • Physics, Medicine
    Technology in cancer research & treatment
  • 2007
The superiority of treatment delivery with protons as contrasted with photons is demonstrated by treatment plans because protons inherently deliver less integral dose and, thus, lead to fewer normal-tissue complications.